507 results on '"Pavord, I."'
Search Results
2. Asthma impacts on workplace productivity in employed patients who are symptomatic despite background therapy: a multinational survey
3. Long-term dupilumab reduces exacerbations and improves lung function in type 2 patients with/without allergic asthma
4. CLINICAL IMPACT OF ASTHMA CONTROL QUESTIONNAIRE SCORE-CUTOFFS WITHIN THE MULTICOMPONENT CLINICAL REMISSION ENDPOINT IN TRAVERSE
5. A novel ct scoring system differentiates admissions secondary to eosinophilic from non-eosinophilic asthma: P227
6. Feno and blood eosinophils as biomarkers in predicting asthma exacerbations: P198
7. Seasonality of eosinophilic and non-eosinophilic exacerbations of copd: P187
8. Lung epithelial cell inhibition of cytokine production by peripheral blood mononuclear cells and lung lymphocytes: P51
9. Regulation of type 2 cytokine release by epithelial cells: characterisation of soluble factor pathways and characterisation of potential mediators: S87
10. Exhaled nitric oxide in the diagnosis of asthma in adults: a systematic review
11. The current and future role of biomarkers in type 2 cytokine‐mediated asthma management
12. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation
13. Blood eosinophils as a marker of likely corticosteroid response in children with preschool wheeze: time for an eosinophil guided clinical trial?
14. What goes up must come down: biomarkers and novel biologicals in severe asthma
15. Clinicians Should Be Proactive in Testing for Asthma
16. FRACTIONAL EXHALED NITRIC OXIDE (FENO) IS A STABLE BIOMARKER IN PATIENTS WITH UNCONTROLLED ASTHMA
17. A Complicated Case Of Community Acquired Pneumonia: Beware Of Drug Induced Side Effects In Critically Ill People
18. The Asthma Control Questionnaire as a clinical trial endpoint: past experience and recommendations for future use
19. Mepolizumab long-term safety in severe eosinophilic asthma.
20. Fractional exhaled nitric oxide as a biomarker in patients with uncontrolled asthma.
21. EAACI position statement on asthma exacerbations and severe asthma
22. Lung function and blood levels of copper, selenium, vitamin C and vitamin E in the general population
23. Sputum eosinophilia in idiopathic pulmonary fibrosis
24. Keeping ‘a chest’ of the literature
25. Phenotyping airways disease: an A to E approach
26. Isolation of filamentous fungi from sputum in asthma is associated with reduced post-bronchodilator FEV1
27. A randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma
28. S144 Acute cough: a longitudinal observational study
29. S140 Predictors of 24-h cough frequency in acute cough
30. S121 Mediator profiling of severe asthma phenotypes
31. S91 Aspergillus fumigatus sensitisation in patients with chronic obstructive pulmonary disease
32. S84 Can clinicians accurately predict non-adherence to medication in patients with difficult asthma? A comparison between clinical judgement and prescription issue data
33. GLUTAMINE SUPPLEMENTATION FOR CYSTIC FIBROSIS - A RANDOMISED CONTROLLED TRIAL: 214
34. Dose-Dependent Anti-inflammatory Effect of Inhaled Mometasone Furoate/Formoterol in Subjects With Asthma and High Baseline Exhaled Nitric Oxide and Sputum Eosinophils: 611
35. S133 Eosinophilic airway inflammation is associated with FEV1 decline in severe asthma
36. S136 Fungal sputum culture in patients with severe asthma is associated with a reduced post bronchodilator FEV1
37. S132 Airway dysfunction and inflammation in pool and non-pool based elite endurance athletes
38. S117 4 h cough frequency monitoring with the Leicester Cough Monitor
39. S33 Suppression of constitutive and stimulated secretion of histamine from human lung mast cells by a secreted factor from lung epithelial cells
40. T6 Acute exacerbations of chronic obstructive pulmonary disease: identification of phenotype-specific biomarkers and biological clusters
41. Expression of CCR8 is increased in asthma
42. CRTH2 expression on T cells in asthma
43. Mepolizumab in refractory eosinophilic asthma
44. The A to E of airway disease
45. Asthma control, airway responsiveness and airway inflammation
46. Assessment of gender differences in health status with the Leicester Cough Questionnaire (LCQ)
47. Sputum IL-5 Concentration Is Associated with a Sputum Eosinophilia and Attenuated by Corticosteroid Therapy in COPD
48. Role of breathing exercises in hyperventilating subjects
49. Breathing exercises for asthma: a randomised controlled trial
50. Biomarkers in the assessment and management of airways diseases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.